Targeting the bone microenvironment in multiple myeloma.

Journal of Bone and Mineral Metabolism
G David Roodman

Abstract

Multiple myeloma (MM) is a plasma cell malignancy characterized by the frequent development of osteolytic lesions, osteopenia, pathological fractures, and/or severe bone pain. In the past few years several potential factors involved in this process have been identified and, with the increased knowledge of the signaling pathways involved in the regulation of normal osteoblast and osteoclast function, have provided us with a better understanding of the contributions of the marrow microenvironment to MM bone disease. These studies have identified several potential novel targets for treating MM bone disease in addition to the current standard treatment of bisphosphonates. In this article, we discuss several potential targets for treating MM bone disease as well as novel therapies that are in clinical trials for these patients.

References

Apr 1, 1993·Clinical and Experimental Immunology·F MericoF Caligaris-Cappio
Mar 13, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J J VinholesR E Coleman
Feb 26, 2000·British Journal of Haematology·A KaradagP I Croucher
Sep 21, 2000·European Journal of Haematology·N AbildgaardE F Eriksen
May 25, 2001·Journal of the American Society of Nephrology : JASN·Glen S MarkowitzVivette D D'Agati
Aug 7, 2001·Seminars in Hematology·N S Callander, G D Roodman
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·R N PearseY Choi
Jun 18, 2002·Blood·Orhan SezerVeit Krenn
Oct 31, 2002·British Journal of Haematology·Sharon GordonMichael J Rogers
Oct 31, 2002·British Journal of Haematology·Raman DesikanSundar Jagannath
Nov 30, 2002·Journal of Pain and Symptom Management·Eugen B PetcuH Smith
Dec 5, 2002·The Journal of Clinical Investigation·M Neale WeitzmannRoberto Pacifici
Jan 22, 2003·Biochemical and Biophysical Research Communications·Gerard BainJackie Papkoff
Dec 26, 2003·The New England Journal of Medicine·Erming TianJohn D Shaughnessy
Mar 9, 2004·Blood Cells, Molecules & Diseases·G David Roodman
Aug 19, 2004·Blood Cells, Molecules & Diseases·Eline MenuKarin Vanderkerken
Oct 12, 2004·Gene·Jennifer J WestendorfTania M Schroeder
Oct 20, 2004·British Journal of Haematology·K J PhekooUNKNOWN Consultant Haematologists, South Thames Haematology Specialist Committee
Mar 5, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Joseph MeltonS Vincent Rajkumar
May 13, 2005·Journal of Behavioral Medicine·Martha M FaradayNeil E Grunberg
Nov 30, 2005·Immunological Reviews·Lori A Ehrlich, G David Roodman
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Jacques BodyPirow J Bekker
Apr 29, 2006·International Journal of Cancer. Journal International Du Cancer·Marianna C PolitouEvangelos Terpos
May 15, 2007·Blood·Evangelos TerposMeletios-Athanassios Dimopoulos
Jun 22, 2007·Leukemia·I von MetzlerO Sezer
Sep 19, 2007·International Journal of Hematology·Shuji OzakiToshio Matsumoto
Mar 12, 2008·European Journal of Haematology·Martin KaiserUlrike Heider

❮ Previous
Next ❯

Citations

Feb 3, 2012·Journal of Bioenergetics and Biomembranes·Ayako NakanoMasahiro Abe
Aug 26, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Kimberly Noonan, Ivan Borrello
Oct 2, 2012·The Journal of Clinical Investigation·W Michael Kuehl, P Leif Bergsagel
Dec 21, 2012·Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology·Saeid AbrounFarahnaz Asghari
Oct 26, 2011·Future Medicinal Chemistry·Angela R Karash, Annette Gilchrist
Oct 8, 2014·Current Opinion in Supportive and Palliative Care·Jesus Delgado-CalleG David Roodman
May 8, 2014·Advances in Hematology·Steven M PrideauxTimothy J Chevassut
Dec 4, 2013·Tissue Engineering. Part C, Methods·Wenting ZhangJenny Zilberberg
Jan 13, 2015·Leukemia & Lymphoma·Anne K MylinUNKNOWN Nordic Myeloma Study Group
Feb 26, 2013·Leukemia & Lymphoma·Fotis AsimakopoulosPeiman Hematti
Oct 2, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·G ShayC C Lynch
Mar 24, 2012·Clinical Lymphoma, Myeloma & Leukemia·Hong LiuBenjamin Bonavida
Jul 22, 2014·Archives of Biochemistry and Biophysics·Marjolein van Driel, Johannes P T M van Leeuwen
Oct 18, 2018·Cell Communication and Signaling : CCS·Hua BaiLijuan Chen
Mar 29, 2019·JBMR Plus·Emily G Atkinson, Jesús Delgado-Calle
Jul 14, 2017·Frontiers in Medicine·Leonardo Freire-de-LimaAlexandre Morrot
Apr 4, 2021·International Journal of Molecular Sciences·Jeng-Shiun DuHui-Hua Hsiao
Apr 6, 2021·Current Osteoporosis Reports·Manish Adhikari, Jesús Delgado-Calle
Sep 29, 2021·Cell Communication and Signaling : CCS·Tingting LiZhiyong Zeng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.